These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

466 related articles for article (PubMed ID: 26294294)

  • 1. Reducing glucocorticoid dosage improves serum osteocalcin in patients with rheumatoid arthritis-results from the TOMORROW study.
    Tada M; Inui K; Sugioka Y; Mamoto K; Okano T; Koike T; Nakamura H
    Osteoporos Int; 2016 Feb; 27(2):729-35. PubMed ID: 26294294
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum concentrations of interleukin 6, osteocalcin, intact parathyroid hormone, and markers of bone resorption in patients with rheumatoid arthritis.
    Al-Awadhi A; Olusi S; Al-Zaid N; Prabha K
    J Rheumatol; 1999 Jun; 26(6):1250-6. PubMed ID: 10381038
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of bisphosphonate might be important to improve bone mineral density in patients with rheumatoid arthritis even under tight control: the TOMORROW study.
    Tada M; Inui K; Sugioka Y; Mamoto K; Okano T; Anno S; Koike T
    Rheumatol Int; 2017 Jun; 37(6):999-1005. PubMed ID: 28405825
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes in (markers of) bone metabolism during high dose corticosteroid pulse treatment in patients with rheumatoid arthritis.
    Lems WF; Gerrits MI; Jacobs JW; van Vugt RM; van Rijn HJ; Bijlsma JW
    Ann Rheum Dis; 1996 May; 55(5):288-93. PubMed ID: 8660101
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Post-menopausal women with rheumatoid arthritis who are treated with raloxifene or alendronate or glucocorticoids have lower serum undercarboxylated osteocalcin levels.
    Mokuda S; Okuda Y; Onishi M; Sawada N; Matoba K; Yamada A; Jouyama K; Takasugi K
    J Endocrinol Invest; 2012 Jul; 35(7):661-4. PubMed ID: 21970822
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early effects of IL-6 receptor inhibition on bone homeostasis: a pilot study in women with rheumatoid arthritis.
    Terpos E; Fragiadaki K; Konsta M; Bratengeier C; Papatheodorou A; Sfikakis PP
    Clin Exp Rheumatol; 2011; 29(6):921-5. PubMed ID: 22032557
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of selected bone metabolism markers in rheumatoid arthritis patients.
    Matuszewska A; Szechiński J
    Adv Clin Exp Med; 2013; 22(2):193-202. PubMed ID: 23709375
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Markers of bone metabolism in postmenopausal women with rheumatoid arthritis. Effects of corticosteroids and hormone replacement therapy.
    Hall GM; Spector TD; Delmas PD
    Arthritis Rheum; 1995 Jul; 38(7):902-6. PubMed ID: 7612039
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of low-dose prednisolone on bone synthesis and resorption in early rheumatoid arthritis: experiences from a two-year randomized study.
    Engvall IL; Svensson B; Tengstrand B; Brismar K; Hafström I;
    Arthritis Res Ther; 2008; 10(6):R128. PubMed ID: 18986531
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IL-6 receptor inhibition positively modulates bone balance in rheumatoid arthritis patients with an inadequate response to anti-tumor necrosis factor therapy: biochemical marker analysis of bone metabolism in the tocilizumab RADIATE study (NCT00106522).
    Karsdal MA; Schett G; Emery P; Harari O; Byrjalsen I; Kenwright A; Bay-Jensen AC; Platt A
    Semin Arthritis Rheum; 2012 Oct; 42(2):131-9. PubMed ID: 22397953
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of methotrexate on bone metabolism markers in patients with rheumatoid arthritis.
    Torikai E; Kageyama Y; Takahashi M; Nagano A
    Mod Rheumatol; 2006; 16(6):350-4. PubMed ID: 17164995
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Uncoupling of bone metabolism in rheumatoid arthritis patients with or without joint destruction: assessment with serum type I collagen breakdown products.
    Garnero P; Jouvenne P; Buchs N; Delmas PD; Miossec P
    Bone; 1999 Apr; 24(4):381-5. PubMed ID: 10221550
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute alteration in bone mineral density and biochemical markers for bone metabolism in nephrotic patients receiving high-dose glucocorticoid and one-cycle etidronate therapy.
    Fujita T; Satomura A; Hidaka M; Ohsawa I; Endo M; Ohi H
    Calcif Tissue Int; 2000 Mar; 66(3):195-9. PubMed ID: 10666494
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Primary prevention of glucocorticoid-induced osteoporosis with intravenous pamidronate and calcium: a prospective controlled 1-year study comparing a single infusion, an infusion given once every 3 months, and calcium alone.
    Boutsen Y; Jamart J; Esselinckx W; Devogelaer JP
    J Bone Miner Res; 2001 Jan; 16(1):104-12. PubMed ID: 11149473
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum concentrations of formation (PINP) and resorption (Ctx) bone turnover markers in rheumatoid arthritis.
    Wisłowska M; Jakubicz D; Stepień K; Cicha M
    Rheumatol Int; 2009 Oct; 29(12):1403-9. PubMed ID: 19219607
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The limited effects of anti-tumor necrosis factor blockade on bone health in patients with rheumatoid arthritis under the use of glucocorticoid.
    Okano T; Koike T; Tada M; Sugioka Y; Mamoto K; Wakitani S; Nakamura H
    J Bone Miner Metab; 2014 Sep; 32(5):593-600. PubMed ID: 24233123
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is bone turnover a determinant of bone mass in rheumatoid arthritis?
    Cortet B; Flipo RM; Pigny P; Duquesnoy B; Boersma A; Marchandise X; Delcambre B
    J Rheumatol; 1998 Dec; 25(12):2339-44. PubMed ID: 9858427
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sex hormones and bone metabolism in postmenopausal rheumatoid arthritis treated with two different glucocorticoids.
    Montecucco C; Caporali R; Caprotti P; Caprotti M; Notario A
    J Rheumatol; 1992 Dec; 19(12):1895-900. PubMed ID: 1294736
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term effects of infliximab on bone and cartilage turnover markers in patients with rheumatoid arthritis.
    Chopin F; Garnero P; le Henanff A; Debiais F; Daragon A; Roux C; Sany J; Wendling D; Zarnitsky C; Ravaud P; Thomas T
    Ann Rheum Dis; 2008 Mar; 67(3):353-7. PubMed ID: 17644538
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Does low-dose and short-term glucocorticoids treatment increase the risk of osteoporosis in rheumatoid arthritis female patients?
    Korczowska I; Olewicz-Gawlik A; Trefler J; Hrycaj P; Krzysztof Łacki J
    Clin Rheumatol; 2008 May; 27(5):565-72. PubMed ID: 17909741
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.